Omega Fund Management, LLC
CIK 1637359 · Holdings on Dec 31, 2023 · First reported Feb 14, 2024
Top ten holdings
Q4 2023- LXEO23.46%
- REPL20.50%
- NUVB18.44%
- 29286M1058.46%
- MORF7.25%
- 85209E1095.13%
- 50107A1043.87%
- 45175G1083.59%
- SANA2.79%
- 88369M1012.33%
Share classes counted separately95.82%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- REPLWeight decreased · -26.67 pp47.17% → 20.50%Shares 0 (0.00%)
- 45175G108Weight decreased · -5.35 pp8.94% → 3.59%Shares 0 (0.00%)
- MORFWeight increased · +0.73 pp6.52% → 7.25%Shares 0 (0.00%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 14
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | LXEOLEXEO THERAPEUTICS INCCommon Stock View history and evidence | $28.96M | 23.46% | 2.16M shares | Prior unavailable +2.16M | New | ↗▾ |
| 02 | REPLREPLIMUNE GROUP INCCommon Stock View history and evidence | $25.30M | 20.50% | 3.00M shares | 47.17% → 20.50%-26.67 pp 0 (0.00%) | Unchanged | ↗▾ |
| 03 | NUVBNUVATION BIO INCCommon Stock Class A View history and evidence | $22.76M | 18.44% | 15.07M shares | 18.55% → 18.44%-0.11 pp 0 (0.00%) | Unchanged | ↗▾ |
| 04 | 29286M105enGene Holdings Inc.Common Stock View history and evidence | $10.44M | 8.46% | 1.13M shares | Prior unavailable +1.13M | New | ↗▾ |
| 05 | MORFMORPHIC HOLDING INCCommon Stock View history and evidence | $8.95M | 7.25% | 309.85K shares | 6.52% → 7.25%+0.73 pp 0 (0.00%) | Unchanged | ↗▾ |
| 06 | 85209E109Spruce BiosciencesCommon Stock View history and evidence | $6.33M | 5.13% | 2.16M shares | 4.49% → 5.13%+0.64 pp 0 (0.00%) | Unchanged | ↗▾ |
| 07 | 50107A104KRONOS BIO INCCommon Stock View history and evidence | $4.77M | 3.87% | 3.82M shares | 4.56% → 3.87%-0.69 pp 0 (0.00%) | Unchanged | ↗▾ |
| 08 | 45175G108Ikena OncologyCommon Stock View history and evidence | $4.43M | 3.59% | 2.25M shares | 8.94% → 3.59%-5.35 pp 0 (0.00%) | Unchanged | ↗▾ |
| 09 | SANASANA BIOTECHNOLOGY INCCommon Stock View history and evidence | $3.44M | 2.79% | 843.75K shares | 3.00% → 2.79%-0.21 pp 0 (0.00%) | Unchanged | ↗▾ |
| 10 | 88369M101Theseus PharmaceuticalsCommon Stock View history and evidence | $2.88M | 2.33% | 711.48K shares | 1.76% → 2.33%+0.57 pp 0 (0.00%) | Unchanged | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 1
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| NVLS ALPINE IMMUNE SCIENCES INC | Non-derivative | -153,700 | -$1.76M | SEC filing ↗ | SEC filing ↗ |
1 / 1 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1637359 · Period 2023-12-31
Data loaded 2026-09-23 · First reported 2024-02-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 123436833
}Take these holdings further.
This page includes 14 of 14 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 14 of 14 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1637359","quarter":"2023Q4","page_size":100}
get_institutional_manager_history
{"cik":"1637359","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.